1,1,1-Trichloro-2-methyl-2-propanol hemihydrate - CAS 6001-64-5
Catalog: |
BB030580 |
Product Name: |
1,1,1-Trichloro-2-methyl-2-propanol hemihydrate |
CAS: |
6001-64-5 |
Synonyms: |
Chlorbutanol Hemihydrate; 1,1,1-Trichloro-tert-butyl Alcohol Hemihydrate; 2,2,2-Trichloro-1,1-dimethylethanol Hemihydrate; 2-(Trichloromethyl)-2-propanol Hemihydrate; Acetochlorone Hemihydrate; Acetonchloroform Hemihydrate; Acetone Chloroform Hemihydrate; Anhydrous chlorobutanol Hemihydrate; Chlorbutol Hemihydrate; Chloreton Hemihydrate; Chloretone Hemihydrate; Chlortran Hemihydrate; Clortran Hemihydrate; Coliquifilm Hemihydrate; Dentalone Hemihydrate; Khloreton Hemihydrate; Methaform Hemihydrate; NSC 44794 Hemihydrate; NSC 4596 Hemihydrate; NSC 5208 Hemihydrate; Sedaform Hemihydrate; Trichloro-tert-butyl Alcohol Hemihydrate; Trichlorobutanol Hemihydrate; β,β,β-Trichloro-tert-butyl Alcohol Hemihydrate |
Related CAS: | 57-15-8 (anhydrous)
|
IUPAC Name: | 1,1,1-trichloro-2-methylpropan-2-ol;hydrate |
Description: | Chlorbutanol Hemihydrate acts as a fish anaesthetic, primarily on members of the octopus species. Also used as an ophthalmic antimicrobial preservative agent (1). |
Molecular Weight: | 186.46 |
Molecular Formula: | C4H7Cl3O.(1/2H2O) |
Canonical SMILES: | CC(C)(C(Cl)(Cl)Cl)O.CC(C)(C(Cl)(Cl)Cl)O.O |
InChI: | InChI=1S/2C4H7Cl3O.H2O/c2*1-3(2,8)4(5,6)7;/h2*8H,1-2H3;1H2 |
InChI Key: | WRWLCXJYIMRJIN-UHFFFAOYSA-N |
Boiling Point: | 173-175°C |
Melting Point: | 77-79°C |
Purity: | 98% |
Solubility: | Soluble in Chloroform (Slightly), Methanol (Slightly) |
Appearance: | White crystalline solid |
Storage: | Store at 2-8°C under inert atmosphere |
MDL: | MFCD00149293 |
LogP: | 2.06320 |
GHS Hazard Statement: | H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral] |
Precautionary Statement: | P261, P264, P270, P271, P280, P301+P312, P302+P352, P304+P340, P305+P351+P338, P312, P321, P330, P332+P313, P337+P313, P362, P403+P233, P405, and P501 |
Signal Word: | Warning |
Publication Number | Title | Priority Date |
EP-3799888-A1 | Liposomes comprising anti-lox antibody | 20191001 |
WO-2021064076-A1 | Liposomes comprising anti-lox antibody | 20191001 |
WO-2021030125-A1 | Cell culture medium for use in producing gene therapy products in bioreactors | 20190809 |
WO-2021026330-A1 | Methods, devices, and systems for administered epinephrine | 20190806 |
WO-2021007382-A1 | Compositions and methods for the treatment of parkinson's disease | 20190709 |
PMID | Publication Date | Title | Journal |
20387991 | 20110301 | Preparation of dry reconstituted liposomal powder by freeze-drying at room temperature | Journal of liposome research |
Complexity: | 83.8 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 3 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 371.920110 |
Formal Charge: | 0 |
Heavy Atom Count: | 17 |
Hydrogen Bond Acceptor Count: | 3 |
Hydrogen Bond Donor Count: | 3 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 369.923061 |
Rotatable Bond Count: | 0 |
Topological Polar Surface Area: | 41.5 Å2 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Oxygen Compounds
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS